Treatment of Urinary Retention in Chronic Cystitis
For urinary retention in chronic cystitis, immediate bladder catheterization with prompt decompression is the first-line management, followed by targeted antimicrobial therapy based on urine culture and susceptibility testing. 1
Diagnostic Approach
Before initiating treatment, confirm the diagnosis with:
- Urine culture and sensitivity testing to identify causative pathogens
- Assessment for structural or functional abnormalities that may contribute to retention
- Evaluation for medication side effects, particularly anticholinergics, that may worsen retention
Management Algorithm
1. Immediate Management
- Bladder catheterization for decompression
2. Antimicrobial Therapy
For uncomplicated cystitis component, use first-line agents based on local antibiogram:
- Nitrofurantoin 100mg twice daily for 5 days 2
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days (if local resistance <20%) 2
- Fosfomycin trometamol 3g single dose 2
For complicated UTI with retention:
- Consider 7-14 day treatment course 2
- For multidrug-resistant organisms, options include:
3. Address Underlying Causes
Medication Review
- Discontinue or reduce medications that can cause urinary retention:
For Inflammatory Component
If interstitial cystitis/chronic inflammatory component is present:
- Amitriptyline starting at low doses (10mg) and titrating gradually to 75-100mg if tolerated 2
- Pentosan polysulfate for long-term management of chronic inflammatory cystitis 2, 5
- Cimetidine for pain and nocturia management 2
4. Long-term Management
- For recurrent episodes, consider:
Special Considerations
For Postmenopausal Women
- Consider vaginal estrogen replacement to prevent recurrent UTIs 2
For Patients with Interstitial Cystitis Features
- Implement behavioral modifications:
- Fluid management strategies
- Avoidance of bladder irritants
- Application of heat or cold over the bladder or perineum 2
Pitfalls and Caveats
- Avoid prolonged catheterization when possible to reduce risk of catheter-associated UTIs
- Do not treat asymptomatic bacteriuria in non-pregnant patients 2
- Avoid empiric fluoroquinolones as first-line therapy due to collateral damage and increasing resistance 2
- Be cautious with anticholinergics like oxybutynin in patients with retention, as they may worsen symptoms 3, 4
- Do not assume all urinary symptoms in chronic cystitis are due to infection - consider interstitial cystitis/bladder pain syndrome in patients with persistent symptoms despite appropriate antimicrobial therapy 2, 5
By following this structured approach, urinary retention in chronic cystitis can be effectively managed while addressing both the acute retention and the underlying inflammatory condition.